M. Hasegawa

发表

Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors.

P. A. Harris, J. Veal, Megumi Shibahara, 2007, Journal of medicinal chemistry.

Anilinopyrazole as selective CDK2 inhibitors: design, synthesis, biological evaluation, and X-ray crystallographic analysis.

Yoshiaki Washio, L. Shewchuk, M. Hasegawa, 2003, Bioorganic & medicinal chemistry letters.

Unprecedented regio- and stereochemical control in the addition of organoaluminum reagents to chiral .alpha.,.beta.-unsaturated acetals

K. Maruoka, M. Hasegawa, Hisashi Yamamoto, 1984 .

Novel naphthalene derivatives as inhibitors of human immunoglobulin E antibody production.

M. Hasegawa, K. Takahashi, T. Takeuchi, 1997, Journal of medicinal chemistry.

Epoxy silyl ether rearrangements: a new, stereoselective approach to the synthesis of .beta.-hydroxy carbonyl compounds

K. Maruoka, Keisuke Suzuki, M. Hasegawa, 1986 .

Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents.

M. Hasegawa, K. Takahashi, Y. Osada, 1993, European journal of pharmacology.

Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees.

T. B. Griffin, M. Hasegawa, Y. Osada, 1993, European journal of pharmacology.

A FACILE ONE-POT SYNTHESIS OF 4-ALKOXY-1,3-BENZENEDICARBONITRILE

M. Hasegawa, 1998 .

A Facile One‐Pot Synthesis of 4‐Alkoxy‐1,3‐benzenedicarbonitrile.

M. Hasegawa, 1998 .